- About 537 million adults globally live with diabetes, with 90–95% of those cases being type 2 diabetes.
- People with diabetes are at an increased risk for several eye health conditions, including diabetic retinopathy and diabetic macular edema.
- Current treatments for diabetic retinopathy and diabetic macular edema are invasive and include medication injections into the eye and laser therapy.
- Data recently released for the phase 1b/2a trial of a new eye drop treatment for diabetic retinopathy and diabetic macular edema reported it to be safe and tolerable with 100% of participants completing the study.
- Researchers also reported a significant decrease in central macular thickness after 85 days of use, as well as inhibition of further increases in vascular leakage in study participants using the eye drop.
About 537 million adults around the world live with diabetes, with 90–95% of those cases being type 2 diabetes.
People with diabetes are at an increased risk for several health problems, including those related to the eyes. These include
There is currently no cure for either diabetic retinopathy or diabetic macular edema. Current treatment options for both conditions include medications injected directly into the eye, laser treatments, and eye surgery.
Soon, a less invasive treatment for diabetic retinopathy and diabetic macular edema may be available in the form of a simple eye drop.
Data recently released from the new treatment’s phase 1b/2a trial reported it to be safe and tolerable, with 100% of participants completing the study.
Additionally, researchers reported a significant decrease in central macular thickness after 85 days of use and inhibition of further increases in vascular leakage.
The researchers will present the full results of the phase 1b/2a trial at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in…
Read the full article here